Troluce Capital Advisors LLC
- SEC CIK
- 0001910321
- Latest filing
- Aug 14, 2026
TCRX holding history
TScan Therapeutics, Inc. in every 13F filed by Troluce Capital Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TCRX overviewAll 13F holders of TCRXFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −150,000−100.0% | Sold out | Holders |
| Q2 2025 | 150,000 | $217.5K | 0.1% | +66,242+79.1% | Added | Holders |
| Q1 2025 | 83,758 | $115.6K | 0.1% | +30,844+58.3% | Added | Holders |
| Q4 2024 | 52,914 | $160.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 52,914 | $263.5K | <0.1% | −39,918−43.0% | Reduced | Holders |
| Q2 2024 | 92,832 | $543.1K | 0.1% | +92,832 | New | Holders |